FOXP3 is expressed in epithelial tissue of breast, lung and prostate where it acts as a tumor-suppressor gene, as proven by the presence of genetic alteration in FOXP3 in human breast cancer samples [23]. The gene discussed is FOXP3; the disease is neoplasm.